Page 7 - GP Fall Final 2017

carefully. Initial biopsies are indicated to Topical fluocinonide 0.05% in an adhesive Christine Macarelli,
confirm the diagnosis of OLP and the pa- base (orabase paste) clinically improved RDH, MS is an Assis-
tient should be reevaluated annually to con- discomfort associated with OLP lesions 13 tant Professor at New
firm that the clinical presentation of disease as has topical betamethasone. Clobetasol York City College of
14
has not changed. Repeat biopsy is indicat- propionate has also been shown to be ef- Technology, where she
ed if the lesion has changed clinically. The fective for OLP. For patients developing teaches Senior Seminar
15
concept of field cancerization must also be secondary oral candidiasis topical antifun- and clinic. Her areas
included when evaluating the possibility gal medication can be prescribed. The most of interest include patients with special
of malignant transformation of OLP , and common are Nystatin suspension, Mycelex needs and dental hygiene educational
12
appropriate referrals for ENT and upper GI troches and Nysatin pastilles. If the patient methodology.
evaluation may be indicated. is xerostomic, or has a propensity to devel-
op oral candidiasis, antifungal agents can Dr. Gwen Cohen
Management/Treatment be prescribed at the same time as the topi- Brown is a full Professor
Topical steroids are effective in treating cal steroids. in the Dental Hygiene
symptomatic OLP. They work by reducing Department, at New
pain and inflammation locally on the tissue Conclusion York City College of
as needed. Since OLP is a chronic condi- OLP is a common chronic mucocutaneous Technology. Dr. Brown
tion, it cannot be cured by use of topical disease which often flares and remits. The received her Bachelor
steroids; therefore, treatment should be re- most pressing concerns are patient com- of Arts degree from Mount Holyoke Col-
served for lesions which are painful. Typ- fort and the potential, although slight, for lege in 1984 and Dental degree from
ically only erosive and/or atrophic lesions malignant transformation. A biopsy is indi- New York University College of Dentist-
need treatment. The hyperkeratotic lesions cated to confirm the diagnosis especially in ry in 1988. Dr. Brown is a licensed den-
do not need to be treated. Systemic cortico- those cases where the patient presents with tist in New York State and a Fellow in
steroids should be reserved for acute exac- a desquamative gingivitis. Treatment is in- the Academy of Oral and Maxillofacial
erbation of OLP or painful lesions whose dicated when the patient is symptomatic. Pathology.
condition is unresponsive to topical ste- Most often these patients will present with Dr. Brown is the Dental Expert for
roids. Several potent topical steroids have atrophic or erosive OLP. As there is a slight WebMD and faculty at the NY/NJ AETC.
been reported to be effective in the treat- risk for the development of oral squamous She is a member of the Dental Standards
of Care Committee charged with writing
ment of symptomatic OLP and can be used cell carcinoma, these patients should be current HIV Clinical Guidelines Pro-
as a first line treatment of OLP without se- monitored and reassessed annually and bi- gram for the NYSDOH/AIDS Institute.
rious side-effects. The most common side opsied if the clinical presentation changes. Dr. Brown authored the current Mono-
12
effect seen in patients using topical steroids graph on Oral Lesions in HIV Sero-
is the development of oral candidiasis sec- References: Please see the online version at positive Patients for the AIDS Institute
ondary to the change in the oral environ- www.nysagd.org. and NYSDOH/NYSDOC. Dr. Brown has
ment. lectured extensively on the topic of HIV/
AIDS, Common Oral Lesions, Infection
Control, and Oral Cancer since 1992.

Dr. Renzo Nylander served as the
President of New York State Academy of
General Dentistry from 1994-1995.

Dr. Nylander’s platform as President
was to make sure that the New York

State AGD kept up with the rapid
changes that effected dentistry. He
believed the answer was quality CE on
the latest technological advances which Dr. Nylander
passed away
was flooding the market in the 90’s. January 29, 2017.
He will be greatly
He also hoped that by the year 2000, missed by his friends Dr. James Keenan with Dr. Joseph
and colleagues at the Haddad, recipient of the AGD Award –
the state would recognize PACE as New York State NYU College of Dentistry, Class of 2017.
state-mandated CE for relicensure, AGD.
which became a reality in 2010.
www.nysagd.org l Fall 2017 l GP 7